Literature DB >> 21225298

The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.

Andreas M Pabst1, Thomas Ziebart, Felix P Koch, Katherine Y Taylor, Bilal Al-Nawas, Christian Walter.   

Abstract

Bisphosphonate-associated osteonecrosis of the jaw (BP-ONJ) is one of the most often seen side effects in patients treated with bisphosphonates, presenting clinically as a non-healing wound. One theory of BP-ONJ etiology describes a negative effect on soft tissues, especially on keratinocytes, which play an important role in oral wound healing and oral soft tissue regeneration. A high cell viability of keratinocytes, which can migrate to the affected location, is essential for wound healing. The aim of this in vitro study was to investigate the effect of differently potent bisphosphonates on human oral keratinocytes (HOK).Three nitrogen-containing bisphosphonates (ibandronate, pamidronate, and zoledronate) and one non-nitrogen-containing bisphosphonate (clodronate) were compared concerning their potency on cell viability (calcein assay and MTT assay), migration ability (Boyden chamber migration assay and scratch wound proliferation assay), and apoptosis (TUNEL assay) of HOK.The nitrogen-containing bisphosphonates, particularly highly potent pamidronate and zoledronate preparations, had a strong negative influence on cell viability, migration ability, and apoptosis of HOK. The non-nitrogen-containing clodronate even increased cell viability in higher concentrations.This study demonstrates that bisphosphonates have a strong influence on HOK on different cellular levels like cell viability, migration ability, and apoptosis rate. The results support the theory that BP-ONJ is a multifactorially caused disease.Furthermore, this in vitro study confirms the theory that perioperative interruption of bisphosphonate application during dental surgical procedures might be feasible to promote better tissue regeneration and wound healing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21225298     DOI: 10.1007/s00784-010-0507-6

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  33 in total

1.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra
Journal:  J Oral Maxillofac Surg       Date:  2009-05       Impact factor: 1.895

Review 2.  Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease.

Authors:  H L Neville-Webbe; R E Coleman
Journal:  Eur J Cancer       Date:  2010-03-27       Impact factor: 9.162

3.  Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.

Authors:  Daniele Santini; Bruno Vincenzi; Giuseppe Avvisati; Giordano Dicuonzo; Fabrizio Battistoni; Michele Gavasci; Alfredo Salerno; Vincenzo Denaro; Giuseppe Tonini
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

4.  Cytotoxicity analysis of alendronate on cultured endothelial cells and subcutaneous tissue. a pilot study.

Authors:  Maria Stella Moreira; Emilio Katayama; Antonio Carlos Bombana; Márcia Martins Marques
Journal:  Dent Traumatol       Date:  2005-12       Impact factor: 3.333

5.  Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.

Authors:  C Walter; A Pabst; T Ziebart; Mo Klein; B Al-Nawas
Journal:  Oral Dis       Date:  2010-08-27       Impact factor: 3.511

6.  Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells.

Authors:  C Walter; M O Klein; A Pabst; B Al-Nawas; H Duschner; T Ziebart
Journal:  Clin Oral Investig       Date:  2009-03-18       Impact factor: 3.573

7.  Inhibition of oral mucosal cell wound healing by bisphosphonates.

Authors:  Regina Landesberg; Matthew Cozin; Serge Cremers; Victoria Woo; Stavroula Kousteni; Satrajit Sinha; LeeAnn Garrett-Sinha; Srikala Raghavan
Journal:  J Oral Maxillofac Surg       Date:  2008-05       Impact factor: 1.895

8.  Oral sodium clodronate induced osteonecrosis of the jaw in a patient with myeloma.

Authors:  Amir H Montazeri; J Gordon Erskine; I Grant McQuaker
Journal:  Eur J Haematol       Date:  2007-07       Impact factor: 2.997

9.  Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis.

Authors:  Mark A Scheper; Ashraf Badros; Risa Chaisuparat; Kevin J Cullen; Timothy F Meiller
Journal:  Br J Haematol       Date:  2008-11-20       Impact factor: 6.998

Review 10.  Esophagitis associated with the use of alendronate.

Authors:  P C de Groen; D F Lubbe; L J Hirsch; A Daifotis; W Stephenson; D Freedholm; S Pryor-Tillotson; M J Seleznick; H Pinkas; K K Wang
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

View more
  42 in total

1.  Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts.

Authors:  Joo-Young Ohe; Yong-Dae Kwon; Hyeon-Woo Lee
Journal:  Clin Oral Investig       Date:  2011-09-22       Impact factor: 3.573

2.  Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation.

Authors:  Nadine Hagelauer; Thomas Ziebart; Andreas M Pabst; Christian Walter
Journal:  Clin Oral Investig       Date:  2014-09-27       Impact factor: 3.573

3.  Compressive force strengthened the pro-inflammatory effect of zoledronic acid on il-1ß stimulated human periodontal fibroblasts.

Authors:  Sarah Grimm; Ambili Mundethu; Judit Symmank; Christoph Hennig; Christian Walter; Elisabeth Reichardt; Heiner Wehrbein; Collin Jacobs
Journal:  Clin Oral Investig       Date:  2020-11-09       Impact factor: 3.573

4.  Isoprenoid geranylgeraniol: the influence on cell characteristics of endothelial progenitor cells after bisphosphonate therapy in vitro.

Authors:  A M Pabst; M Krüger; T Ziebart; C Jacobs; C Walter
Journal:  Clin Oral Investig       Date:  2015-01-16       Impact factor: 3.573

5.  Influence of clodronate and compressive force on IL-1ß-stimulated human periodontal ligament fibroblasts.

Authors:  Sarah Grimm; Eva Wolff; Christian Walter; Andreas M Pabst; Ambili Mundethu; Cornelius Jacobs; Heiner Wehrbein; Collin Jacobs
Journal:  Clin Oral Investig       Date:  2019-05-17       Impact factor: 3.573

6.  The effects of ozone application on genotoxic damage and wound healing in bisphosphonate-applied human gingival fibroblast cells.

Authors:  Sıdıka Sinem Akdeniz; E Beyler; Y Korkmaz; E Yurtcu; U Ates; K Araz; F I Sahin; O Y Torun
Journal:  Clin Oral Investig       Date:  2017-07-11       Impact factor: 3.573

7.  Low concentration amino-bisphosphonates stimulate human keratinocyte proliferation and in vitro wound healing.

Authors:  Filippo Renò; Mario Migliario; Manuela Rizzi; Marco Invernizzi; Carlo Cisari; Mario Cannas
Journal:  Int Wound J       Date:  2011-12-19       Impact factor: 3.315

8.  Effect of low-level laser therapy on oral keratinocytes exposed to bisphosphonate.

Authors:  Jae-Yeol Lee; In-Ryoung Kim; Bong-Soo Park; Yong-Deok Kim; In-Kyo Chung; Jae-Min Song; Sang-Hun Shin
Journal:  Lasers Med Sci       Date:  2013-07-09       Impact factor: 3.161

9.  Radiologic bone loss in patients with bisphosphonate-associated osteonecrosis of the jaws: a case-control study.

Authors:  Christian Walter; Christian Laux; Keyvan Sagheb
Journal:  Clin Oral Investig       Date:  2013-03-23       Impact factor: 3.573

10.  Mechanical loading influences the effects of bisphosphonates on human periodontal ligament fibroblasts.

Authors:  Collin Jacobs; Christian Walter; Thomas Ziebart; Isabelle Dirks; Sabrina Schramm; Sarah Grimm; Elena Krieger; Heinrich Wehrbein
Journal:  Clin Oral Investig       Date:  2014-07-25       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.